Every Form 4 that IDEX Corporation (IEX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IEX filings page.
IDEX CORP (IEX) reported that officer Tara M. Tereso, Group Executive, HST, had 290 shares of common stock disposed of on September 16, 2026 as a payment of exercise price or tax liability by delivering or withholding securities at a price of $222.84 per share. Following this transaction, Tereso directly holds 5,408 shares of IDEX common stock, and no Rule 10b5-1 trading plan is reported.
IDEX CORP (IEX) reported that executive William L. Simmons, Group Executive, FMT & FSDP, had 218 shares of common stock disposed of on September 16, 2026 as a payment of exercise price or tax liability by delivering or withholding securities. Following this transaction, he directly holds 2,674 shares of IDEX common stock. No Rule 10b5-1 trading plan is reported.
IDEX CORP (IEX) reported that officer Tara M. Tereso, Group Executive, HST, had 138 shares of common stock delivered or withheld on September 11, 2026 for payment of exercise price or tax liability, at a recorded value of $221.46 per share. After this transaction, Tereso directly holds 5,698 common shares. No Rule 10b5-1 trading plan is reported for this transaction.
IDEX CORP (IEX) reported an insider transaction by Allison S. Lausas, Vice President and Chief Accounting Officer. On 2026-08-29, she disposed of 645 shares of common stock classified as a payment of exercise price or tax liability by delivering or withholding securities, at a reported price of $230.28 per share. Following this withholding-related disposition, she held 3,302 shares of IDEX common stock directly.
IDEX Corp senior executive Lisa M. Anderson, SVP, GC, CAO & Corporate Secretary, exercised options to acquire 385 shares of common stock at an exercise price of $93.27 per share, originally granted with an exercise date of February 22, 2018 and expiring February 22, 2027. On the same day, she sold 385 shares of common stock at a weighted average price of $238.5949 per share, with individual trade prices ranging from $238.39 to $238.73. Following the transaction, the reported option position of 385 options was reduced to 0.
IDEX Corp CEO and President Eric D. Ashleman reported an option exercise and share sales. On May 11, 2026, he exercised options for 15,385 shares of common stock at an exercise price of $93.27 per share. The same day, he completed two open-market sales totaling 15,385 shares of common stock, selling 4,915 shares at a weighted average price of $215.8115 and 10,470 shares at $214.9457, with each trade executed in multiple transactions within stated price ranges. Following these transactions, he directly owned 66,658 shares of IDEX common stock.
Watts Stanfield Paris reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Stanfield Paris Watts received an equity award of 805 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of IDEX common stock. Following this grant, the director holds 4,195 shares of common stock.
The RSUs vest in full on the earlier of May 6, 2027, or the date of IDEX’s next annual stockholders meeting, if that meeting occurs at least 50 weeks after the prior year’s meeting. Vesting is conditioned on the director’s continuous service through the vesting date.
Quiroz Alejandro reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Alejandro Quiroz reported an equity award of 805 shares of common stock, received as a grant of restricted stock units (RSUs). Each RSU represents a right to receive one share of IDEX common stock if vesting conditions are met.
The RSUs vest in full on the earlier of May 6, 2027, or the date of the next annual stockholders meeting, provided that meeting occurs at least 50 weeks after the prior year’s meeting and Quiroz remains in continuous service through that date. Following this award, he directly holds 4,030 shares of common stock.
IDEX CORP director Katrina L. Helmkamp received an equity award of 1,035 shares of common stock in the form of restricted stock units. The award was granted at a price of $0.00 per share as compensation, not as an open-market purchase.
After this grant, Helmkamp directly holds 14,235 shares of IDEX common stock. Each RSU converts into one share of common stock and vests in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, provided that meeting occurs at least 50 weeks after the prior year’s meeting and she remains in continuous service through the vesting date.
Gunter Lakecia N reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Lakecia N. Gunter received an equity award of 805 shares of common stock on May 6, 2026. The award is in the form of restricted stock units, each representing a contingent right to one share of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, if that meeting occurs at least 50 weeks after the prior year’s meeting, and only if Gunter continues in service through the vesting date. After this grant, Gunter directly holds 4,925 shares of IDEX common stock.
IDEX Corp director Matthijs Glastra received a stock-based award. On May 6, 2026, he acquired 805 shares of common stock through a grant of restricted stock units at no cash cost, increasing his direct holdings to 1,880 shares. These RSUs vest in full on May 6, 2027 or at the next annual stockholders meeting held at least 50 weeks after the prior year's meeting, contingent on his continuous service.
Disher Stephanie reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Stephanie Disher received an equity award in the form of restricted stock units. On May 6, 2026, she was granted 805 RSUs, each representing a contingent right to receive one share of IDEX common stock at no purchase price.
These RSUs vest in full on May 6, 2027, or on the date of the company’s next annual stockholders meeting if that meeting occurs at least 50 weeks after the prior year’s meeting, subject to her continuous service. Following this award, she holds 1,880 shares of common stock directly.
IDEX CORP director Carl R. Christenson received an equity award of 805 shares of common stock in the form of restricted stock units. These RSUs convert into one share each when they vest. Following this grant, he directly holds 7,156 shares of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027, or the date of the company’s next annual stockholders meeting if it occurs at least 50 weeks after the prior year’s meeting, assuming he continues in service through the vesting date.
BUTHMAN MARK A reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Mark A. Buthman received an equity award in the form of restricted stock units. On May 6, 2026 he was granted 805 RSUs, each representing a contingent right to receive one share of IDEX common stock.
The RSUs vest in full on the earlier of May 6, 2027 and the date of IDEX’s next annual stockholders meeting, if that meeting is at least 50 weeks after the prior year’s meeting, and only if he remains in continuous service through the vesting date. Following this grant, he directly owns 10,025 shares of common stock.
Beck Mark A reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP director Mark A. Beck received an equity award in the form of 805 shares of common stock on May 6, 2026, reported at a price of $0.00 per share as a grant.
The award is structured as restricted stock units, each representing one share of common stock, and will vest in full on the earlier of May 6, 2027, or the date of the company’s next annual stockholders meeting if that meeting occurs at least 50 weeks after the prior year’s meeting, subject to his continued service. Following this grant, Beck directly holds 7,755 shares of IDEX common stock.
IDEX CORP executive Tara M. Tereso reported equity compensation changes and related tax withholding. On February 19, 2026, she acquired an award of 1,055 shares of common stock and 4,445 stock options at an exercise price of $0.0000 per option, described as grants or awards. The restricted shares vest in three roughly equal annual installments beginning February 19, 2027, and the options vest in four roughly equal annual installments beginning the same date, in each case conditioned on continued service.
On February 23, 2026, 154 shares of common stock were disposed of at a price of $207.48 per share to satisfy tax withholding obligations, a non‑market “F” code transaction. After these transactions, Tereso directly held 5,836 shares of common stock and 4,445 options.
Simmons William L. reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP officer William L. Simmons reported equity awards rather than open-market trades. On February 19, 2026, he received options to buy 4,445 shares of common stock and an award of 1,055 restricted stock units. The RSUs each represent a right to one share of common stock and vest in three substantially equal annual installments beginning February 19, 2027, contingent on continued service. The stock options vest in four substantially equal annual installments beginning on the same date, also subject to his continued service.
IDEX CORP reported insider equity awards and a related tax share disposition for Vice President and Chief Accounting Officer Allison S. Lausas.
On February 19, 2026, Lausas received a grant of 275 shares of common stock and an award of 1,145 stock options, both at a stated price of $0.0000 per share. The restricted shares vest in three substantially equal annual installments beginning February 19, 2027, while the options vest in four substantially equal annual installments beginning the same date, in each case subject to continued service.
On February 20, 2026, Lausas disposed of 179 shares of common stock at $207.86 per share in a tax-withholding disposition. Following these transactions, she directly owned 3,947 shares of common stock and 1,145 stock options.
Gillen Sean M. reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP reported that its SVP and Chief Financial Officer, Sean M. Gillen, received new equity awards. He was granted 10,160 options to buy common stock and 2,410 restricted shares on February 19, 2026. The restricted shares vest in three substantially equal annual installments beginning February 19, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to his continuous employment. These awards increase his direct equity stake in the company and are designed to align his compensation with long-term company performance.
ASHLEMAN ERIC D reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP CEO and President Eric D. Ashleman reported equity awards rather than open-market trades. He received 38,165 options to buy IDEX common stock and a separate grant of 9,040 shares of common stock, awarded at a stated price of $0.00 per share as compensation.
The 9,040-share award represents restricted stock units, each convertible into one share of common stock. These RSUs vest in three substantially equal annual installments beginning February 22, 2027, conditioned on his continued service. The stock options vest in four substantially equal annual installments starting on the same date, also subject to continued service.
Anderson Lisa M reported acquisition or exercise transactions in this Form 4 filing.
IDEX CORP senior executive Lisa M. Anderson, who serves as SVP, General Counsel, Chief Administrative Officer and Corporate Secretary, reported equity compensation awards. She received options for 5,080 shares of common stock and a grant of 1,205 restricted shares, both at a price of $0.00 per share as part of her compensation.
The restricted shares vest in three substantially equal annual installments starting on February 19, 2027, contingent on her continuous service. The stock options vest in four substantially equal annual installments beginning on the same date, also conditioned on continued service. After these awards, she directly holds 4,327 common shares and 5,080 options.
IDEX Corporation reported an equity grant to its senior vice president and chief financial officer, Sean M. Gillen. On 01/05/2026, he received 16,595 shares of common stock at a price of $0 per share as an equity award. These are restricted shares that vest in three substantially equal annual installments on each of the first, second and third anniversaries of the grant date, conditioned on his continued employment through each vesting date. Following this award, Gillen beneficially owns 16,595 shares of IDEX common stock in direct form.
IDEX Corporation (IEX) filed a Form 4 reporting an insider purchase. A company director bought 600 shares of common stock on 11/05/2025 at a weighted average price of $169.4112. Following the transaction, the director beneficially owns 6,351 shares, held directly.
The filing notes the trade was executed in multiple lots with prices ranging from $169.35 to $169.43. The weighted average reflects those individual executions, and the reporting person undertakes to provide the specific trade breakdown upon request.